2006
DOI: 10.1590/s0101-60832006000700004
|View full text |Cite
|
Sign up to set email alerts
|

Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 2: tratamento de longo prazo

Abstract: ResumoEstas diretrizes para o tratamento biológico da esquizofrenia foram desenvolvidas pela Força-Tarefa da Federação Mundial das Sociedades de Psiquiatria Biológica (World Federation of Societies of Biological Psychiatry, WFSBP). As metas fixadas durante o desenvolvimento destas diretrizes foi a revisão sistemática de todas as evidências disponíveis referentes ao tratamento da esquizofrenia, tanto no âmbito clínico como no científico, e o estabelecimento de um consenso sobre as principais recomendações para … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 127 publications
(175 reference statements)
0
3
0
Order By: Relevance
“…The costs of atypical medications, however, are much higher than the typical ones, with a limited number of second generation antipsychotics. In addition, patients must be within the program criteria, which includes not showing improvement with conventional treatment, the need for a medicalpsychiatric report based on the assessment of psychological impairment made by the BPRS-A; for maintenance of treatment, an improvement of at least 30% after 3 months of treatment so that there is a substitution for atypical medication (4,29) .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The costs of atypical medications, however, are much higher than the typical ones, with a limited number of second generation antipsychotics. In addition, patients must be within the program criteria, which includes not showing improvement with conventional treatment, the need for a medicalpsychiatric report based on the assessment of psychological impairment made by the BPRS-A; for maintenance of treatment, an improvement of at least 30% after 3 months of treatment so that there is a substitution for atypical medication (4,29) .…”
Section: Discussionmentioning
confidence: 99%
“…However, there is a loss in this effect, when associated with a typical, a fact identified in clinical practices. Moreover, the association of two or more antipsychotics can cause cardiotoxicity by increasing the QT interval (electrocardiographic parameter that represents the electrical systole duration) (28)(29)(30) . These findings may suggest that patients may be at greater risk of developing cardiotoxicity, as 24 patients are associated with more than one type of typical and atypical antipsychotic, and 8 use deposit medication, typical and atypical.…”
Section: Discussionmentioning
confidence: 99%
“…Long term treatment is indicated for all patients with schizophrenia 1 . Antipsychotic drugs can be of great benefit for a wide range of psychotic disorders, although treatment can be associated with potential and unpleasant adverse effects 2 .…”
Section: Introductionmentioning
confidence: 99%